Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)

Artigo Acesso aberto Revisado por pares

Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)

2007; AlphaMed Press; Volume: 12; Issue: 10 Linguagem: Inglês

10.1634/theoncologist.12-10-1215

ISSN

1549-490X

Autores

Gianpiero Fasola, Ornella Belvedere, Marianna Aita, Tina Zanin, Alessandro Follador, Paolo Cassetti, Stefano Meduri, V. De Pangher, Giusto Pignata, Valentina Rosolen, Fabio Barbone, Francesco Grossi,

Tópico(s)

Pleural and Pulmonary Diseases

Resumo

Learning Objectives After completing this course, the reader will be able to: Describe the current status of LDCT screening for lung cancer among high-risk individuals.Discuss the potential and drawbacks of LDCT for the early detection of lung cancer in asbestos-exposed individuals.Describe the limits and possibilities of LDCT for detecting pleural abnormalities and malignant pleural mesothelioma in asbestos workers and former workers. Access and take the CME test online and receive 1 AMA PRA Category 1 Credit™ at CME.TheOncologist.com

Ver no editor

Altmetric

PlumX

Entrar

Lembrar minha senha

Receber meu e-mail de confirmação

Low-Dose Computed Tomography Screening for Lung Cancer and Pleural Mesothelioma in an Asbestos-Exposed Population: Baseline Results of a Prospective, Nonrandomized Feasibility Trial—An Alpe-Adria Thoracic Oncology Multidisciplinary Group Study (ATOM 002)